BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4060249)

  • 1. Estrogen and progesterone receptors in breast carcinoma and in nonmalignant breast tissue.
    Gion M; Mione R; Dittadi R; Griggio L; Munegato G; Valescchi M; Del Maschio O; Fasan S; Bruscagnin G
    Tumori; 1985 Oct; 71(5):477-81. PubMed ID: 4060249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
    Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medullary carcinoma of the breast: an association with negative hormonal receptors.
    Ponsky JL; Gliga L; Reynolds S
    J Surg Oncol; 1984 Feb; 25(2):76-8. PubMed ID: 6694404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the content of estrogen and progesterone receptors and the pathological characteristics in human breast cancer.
    Nishimura R; Misumi A; Kimura M; Tokunaga T; Akagi M
    Jpn J Surg; 1982; 12(3):191-7. PubMed ID: 6290728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical analysis of receptors for estrogen and progesterone in fine-needle aspirates from human breast carcinomas.
    Skoog L; Humla S; Isaksson S; Tani E
    Diagn Cytopathol; 1990; 6(2):95-8. PubMed ID: 2186900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of estrogen and progesterone receptors with histologic differentiation in mammary carcinoma.
    McCarty KS; Barton TK; Fetter BF; Woodard BH; Mossler JA; Reeves W; Daly J; Wilkinson WE; McCarty KS
    Cancer; 1980 Dec; 46(12 Suppl):2851-8. PubMed ID: 6256054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlations between receptor state and various clinico-morphological parameters: evaluation of circa 2000 cases of breast tumors].
    Lampertico P; Stagni F
    Pathologica; 1985; 77(1049):281-97. PubMed ID: 3008068
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiestrogen binding sites in microsomal fractions of malignant and nonmalignant human breast tissues.
    Mehta RR; DasGupta TK
    Breast Cancer Res Treat; 1987; 9(1):61-7. PubMed ID: 3593991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of dextran-coated charcoal and sucrose density gradient analyses of estrogen and progesterone receptors in human breast cancer.
    Anderson KM; Bonomi P; Marogil M; Hendrickson C; Economou S
    Cancer Res; 1980 Nov; 40(11):4127-32. PubMed ID: 6162545
    [No Abstract]   [Full Text] [Related]  

  • 10. Steroid-hormone receptors in nonpalpable and more advanced stages of breast cancer. A contribution to the biology and natural history of carcinoma of the female breast.
    Tinnemans JG; Beex LV; Wobbes T; Sluis RF; Raemaekers JM; Benraad T
    Cancer; 1990 Sep; 66(6):1165-7. PubMed ID: 2400967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoembryonic antigen and steroid receptors in the cytosol of carcinoma of the breast. Relationship to pathologic and clinical features.
    Schwartz MR; Randolph RL; Panko WB
    Cancer; 1985 May; 55(10):2464-71. PubMed ID: 3986741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosol and nuclear estrogen receptors (occupied and unoccupied sites) and progesterone receptors in human breast cancer.
    Sumida C; Magdelenat H; Pasqualini JR
    Breast Cancer Res Treat; 1985; 5(2):165-9. PubMed ID: 4016282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of fine-needle aspirates of breast cancers to evaluate hormone-receptor status.
    Lundy J; Lozowski M; Sadri D; Mishriki Y
    Arch Surg; 1990 Feb; 125(2):174-6. PubMed ID: 2302058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of estrogen and progesterone receptors in healthy tissue adjacent to breast lesions at various stages--immunohistochemical study of 107 cases.
    Jacquemier JD; Hassoun J; Torrente M; Martin PM
    Breast Cancer Res Treat; 1990 Feb; 15(2):109-17. PubMed ID: 2322649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic breast carcinoma with positive estrogen and progesterone receptors in a man with Klinefelter's syndrome.
    Ellison HS; Scheuer SA; Eichner ER
    South Med J; 1980 Oct; 73(10):1393-6. PubMed ID: 7434059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunohistochemical determination of estrogen receptors in breast carcinoma tissue using monoclonal antibodies. 1st clinical findings].
    Jonat W; Stegner HE; Maass H
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):473-6. PubMed ID: 3896915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progesterone receptors revealed by an immunoperoxidase method.
    Pelusi G; D'Errico A; Cavallina R; Cunsolo A; Jasonni VM; Eusebi V
    Eur J Gynaecol Oncol; 1983; 4(2):94-6. PubMed ID: 6191985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and progesterone receptors in epithelial ovarian malignancies.
    Sutton GP; Senior MB; Strauss JF; Mikuta JJ
    Gynecol Oncol; 1986 Feb; 23(2):176-82. PubMed ID: 3943759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and progesterone receptors in breast cancer: relationships to tumour histopathology and survival of patients.
    Blanco G; Alavaikko M; Ojala A; Collan Y; Heikkinen M; Hietanen T; Aine R; Taskinen PJ
    Anticancer Res; 1984; 4(6):383-9. PubMed ID: 6097159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical determination of estrogen and progesterone receptors in human breast carcinoma. Correlation with histopathology and DNA flow cytometry.
    Helin HJ; Helle MJ; Kallioniemi OP; Isola JJ
    Cancer; 1989 May; 63(9):1761-7. PubMed ID: 2649227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.